The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksFD Technologies Regulatory News (FDP)

Share Price Information for FD Technologies (FDP)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,224.00
Bid: 1,220.00
Ask: 1,224.00
Change: -6.00 (-0.49%)
Spread: 4.00 (0.328%)
Open: 1,200.00
High: 1,232.00
Low: 1,200.00
Prev. Close: 1,230.00
FDP Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

FY24 Trading Update

1 Mar 2024 07:00

RNS Number : 0688F
FD Technologies PLC
01 March 2024
 

1 March 2024

 

FD Technologies plc

("FD Technologies", the "Company" or the "Group")

 

FY24 Trading Update - KX and First Derivative Performance

 

FD Technologies (AIM: FDP.L, Euronext Growth: FDP.I) announces an update on trading for the year to 29 February 2024.

 

A separate RNS has also been released providing an update on the conclusion of the structure review and a merger of MRP with CONTENTgine.

 

We anticipate that Group revenue will be slightly below consensus at not less than £247m, and adjusted EBITDA will be in line with consensus at not less than £22.5m*. These anticipated results exclude MRP, which will no longer be consolidated in our financial statements following the announcement of its merger with CONTENTgine referred to above.

 

The revenue performance for the Group was impacted by the prevailing macro-economic conditions and some short-term challenges in KX, which we are proactively addressing as detailed in the overview below.

 

KX performance

 

KX is expected to report annual contract value (ACV) added of approximately £7m in the second half of the financial year, making total ACV for the year of approximately £14m. This is expected to result in ARR growth at constant currency for the year of not less than 12%.

 

The lower than expected FY24 ARR growth at KX is due to the following factors:

 

· Despite early wins in H1, we have seen a lower conversion ratio and longer sales cycles, particularly in the joint Cloud Service Provider (CSP) pipeline for our newer industry sectors which we attribute to having fewer repeatable use cases and lower brand recognition

· Delayed decision making on a small number of larger contracts expected to be signed during H2 which have slipped into FY25 as customers require more time to complete their purchasing process, in addition to sales cycles generally lengthening due to macro headwinds.

 

To address these issues, we have implemented the following measures:

 

· Upgraded our sales leadership through the appointment of Clint Maddox as Chief Revenue Officer in February 2024 and Peter Finter as Chief Marketing Officer in September 2023. Clint Maddox has a strong track record of sales leadership success in enterprise technology and channel distribution at companies including Broadcom and CA. He brings the experience needed to scale our sales processes and increase efficiency. Peter Finter has experience building marketing strategies at hyper-growth technology companies and is focused on driving down customer acquisition costs, expanding brand awareness beyond capital markets, and positioning KX as the engine for AI workflows

· Focused more direct sales resources on repeatable use cases in financial services and aerospace and defence which combined accounted for more than 80% of our FY24 ACV

· Other industry markets will be served through partner channels with strong brand recognition including CSPs, Systems Integrators and OEMs. Despite the short-term challenges in H2, the CSP channel remains strategic, and we expect stronger conversion rates as we refine our joint sales processes and add more customer references and use cases.

 

The lower level of ARR has not materially affected KX FY24 reported revenue or adjusted EBITDA. We are optimising our cost base for FY25 and focusing our investment on the areas of highest return and following these actions we will be better placed to give detailed guidance with our FY24 results** as well as update on our H1 FY25 progress. Given the high level of predictability of our reported revenue and our current cost plans, we expect that KX cash EBITDA in FY25 will be slightly improved compared to FY24.

 

Despite the ARR performance for the year, the unique capabilities and differentiation of the KX technology continue to be consistently confirmed by our customers and partners. The action we have taken on sales and marketing leadership and processes will enable us to deliver stronger and more sustainable returns in the future.

 

The key drivers of sustainable growth in FY25 and beyond are:

 

· Established, repeatable use cases with improved time to value in capital markets using standard configurations and cloud infrastructure, supporting quantitative research and trading strategies across many hundreds of financial institutions of all sizes

· Building on initial wins, aerospace and defence has solidified as a major sector for our technology responsible for approximately 25% of FY24 new business and will be important for FY25 and beyond, supporting engineering and warfare scenario simulation

· We delivered a major release of kdb+ (release 4.1), the foundational analytical database engine for all of our product range, with 15 of our most advanced customers already benefiting from the new, improved performance and functionality

· We are able to attract new audiences and provide value through our native Python integration 'PyKX'. With over 150,000 downloads and 25 customers, Python is central to our go-forward pipeline and ability to win new logos, add new workloads and bring high performance analytics to our customers and partners

· We continue to work with the CSPs on joint market propositions in capital markets but also in generative AI and as an OEM component within sector-specific solutions

· Following our increased investment, we are seeing accelerating activity in generative AI. Our investment in KDB.AI has allowed us to explore and validate highly differentiated use cases with key clients. This success builds confidence in establishing repeatable use cases within this burgeoning market, which will in turn drive revenue growth in FY25 and beyond.

 

First Derivative performance

 

At First Derivative customer spending caution continued to be evident through the second half of the financial year. FY24 revenue is expected to be approximately £170m, which is 7% lower than FY23, although we were able to maintain EBITDA margin by managing our costs. Looking ahead, there are encouraging signs of improved customer sentiment although it remains too early to forecast the timing of a return to revenue growth.

 

Seamus Keating, Group CEO, said: "While the Group's revenue and adjusted EBITDA performance is broadly in line with our guidance, the KX ARR growth is disappointing. The slower growth reflects the weaker macro environment and some areas where we need to improve. We have moved quickly to strengthen our sales leadership and to ensure that the greatest focus is on repeatable use cases in financial services and aerospace and defence where we have a clear competitive advantage. With these operational improvements in place, we believe that our technology and market opportunity are compelling and that KX will deliver stronger, more sustainable growth and value for shareholders."

 

Analyst call

A presentation for institutional analysts will be held at 8.30am today via Zoom. Please contact FDtechnologies@fticonsulting.com for joining details.

 

*Company-compiled analyst consensus excluding MRP is for revenue of £254m, adjusted EBITDA of £22.5m and KX ARR of £83m

** FY24 full year results will be released on 21 May 2024

 

 

For further information, please contact:

 

FD Technologies plc

Seamus Keating, Chief Executive Officer

Ryan Preston, Chief Financial Officer

Ian Mitchell, Head of Investor Relations

+44(0)28 3025 2242

www.fdtechnologies.com

Investec Bank plc

(Nominated Adviser and Broker)

Carlton Nelson

Virginia Bull

+44 (0)20 7597 5970

Goodbody (Euronext Growth Adviser and Broker)

Tom Nicholson

Don Harrington

Jason Molins

+353 1 667 0420

 

J.P. Morgan Cazenove (Broker)

James A. Kelly

Mose Adigun

+44 (0)20 3493 8000

 

FTI Consulting

Matt Dixon

Dwight Burden

Victoria Caton

+44 (0)20 3727 1000

 

 

About FD Technologies

FD Technologies is a group of data-driven businesses that unlock the value of insight, hindsight and foresight to drive organisations forward. The Group comprises KX, which provides software to accelerate AI-driven innovation and First Derivative, providing consulting services which drive digital transformation in financial services and capital markets. FD Technologies operates from 13 locations across Europe, North America and Asia Pacific, and employs more than 2,400 people worldwide.

 

For further information, please visit www.fdtechnologies.com and www.kx.com

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTPPUAUPUPCPWB
Date   Source Headline
23rd Apr 20247:00 amRNSNotice of Results
22nd Apr 20244:11 pmRNSHolding(s) in Company
22nd Apr 20247:00 amRNSHolding(s) in Company
15th Apr 20246:14 pmRNSIssue of Equity
8th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:53 pmRNSHolding(s) in Company
4th Apr 20244:14 pmRNSHolding(s) in Company
2nd Apr 20243:43 pmRNSHolding(s) in Company
2nd Apr 20243:26 pmRNSHolding(s) in Company
2nd Apr 20248:39 amRNSTotal Voting Rights
2nd Apr 20247:00 amRNSHolding(s) in Company
28th Mar 20243:24 pmRNSHolding(s) in Company
19th Mar 20244:35 pmRNSIssue of Equity
18th Mar 20244:22 pmRNSHolding(s) in Company
15th Mar 20246:23 pmRNSHolding(s) in Company
15th Mar 20245:27 pmRNSCorrection - Holding(s) in Company
15th Mar 20245:20 pmRNSHolding(s) in Company
15th Mar 20244:43 pmRNSHolding(s) in Company
13th Mar 20245:15 pmRNSHolding(s) in Company
13th Mar 20244:34 pmRNSHolding(s) in Company
13th Mar 202410:45 amRNSHolding(s) in Company
11th Mar 202412:15 pmRNSHolding(s) in Company
11th Mar 202411:47 amRNSDirector/PDMR Shareholding
7th Mar 202410:57 amRNSHolding(s) in Company
6th Mar 20244:50 pmRNSHolding(s) in Company
6th Mar 20247:00 amRNSHolding(s) in Company
4th Mar 20247:00 amRNSHolding(s) in Company
1st Mar 20247:00 amRNSConclusion of Structure Review
1st Mar 20247:00 amRNSFY24 Trading Update
15th Jan 20245:43 pmRNSHolding(s) in Company
19th Dec 20235:27 pmRNSCorrection: Holding(s) in Company
18th Dec 20237:00 amRNSHolding(s) in Company
15th Dec 20237:00 amRNSDirectorate Change
29th Nov 20237:00 amRNSKX hosts Investor Event: Winning in the AI Era
28th Nov 20237:00 amRNSLaunch of KDB.AI Server
22nd Nov 20231:54 pmRNSHolding(s) in Company
16th Nov 20237:00 amRNSDirector/PDMR Shareholding
14th Nov 20238:57 amRNSDirector/PDMR Shareholding
13th Nov 20233:04 pmRNSHolding(s) in Company
6th Nov 20237:00 amRNSNotice of KX Investor Event
24th Oct 20237:00 amRNSResults for the six months ended 31 August 2023
2nd Oct 20237:00 amRNSNotice of Results
31st Aug 20239:18 amRNSTotal Voting Rights
15th Aug 20237:00 amRNSIssue of Equity
31st Jul 20231:59 pmRNSTotal Voting Rights
20th Jul 20233:30 pmRNSResult of AGM
28th Jun 20234:17 pmRNSPDMR Notice and Issue of Equity
27th Jun 20234:30 pmRNSNotice of AGM
5th Jun 202312:43 pmRNSHolding(s) in Company
30th May 20231:01 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.